The online community for biotechnology industry of Switzerland.

SuisseBio has seen steady growth since 2004 and is expected to continue to expand. The Swiss biopharmaceutical market’s strength lies in the ability to carry products to the final stage of development. Switzerland ranks second in the number of pipelines in all phases according to Ernst & Young. Although Switzerland is a smaller country, its success has placed this Hotbed in the company of the world’s most successful biotechnology markets.

Join the World Discussion Forum

Click here to Search Jobs

Hotbed News
MYMETICS Corporation Announces New Collaboration To Advance The Development Of An Innovative Malaria Vaccine Candidate Tuesday, November 18, 2014
Roche (RHHBY) Wins FDA Approval For Strep A Test Thursday, November 13, 2014
Celgene (CELG) Receives Positive CHMP Opinion For OTEZLA (apremilast), The First Oral PDE4 Inhibitor For The Treatment Of Patients With Psoriasis And Psoriatic Arthritis Friday, November 21, 2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia Thursday, November 13, 2014
Artificial Nanoparticles A Possible Alternative To Antibiotics, University of Bern Study Tuesday, November 04, 2014
Novartis AG (NVS)'s Panobinostat Fails To Win FDA Panel Support Monday, November 10, 2014
Merck & Co. (MRK) Announces Positive Study Investigating The Use Of KEYTRUDA® (pembrolizumab) Compared To Chemotherapy In Patients With Ipilimumab-Refractory Advanced Melanoma Tuesday, November 18, 2014
The Growing Presence Of Biotech In The World Of Social Media Friday, November 21, 2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes Friday, November 14, 2014
Babies Die While Officials Haggle With Novartis AG (NVS) Over Cost Of Bexsero Vaccine Wednesday, November 12, 2014